SequelSEC

BECTON DICKINSON & CO BDX

Surgical & Medical Instruments & Apparatus · CIK 0000010795 · Fiscal year ends 0930

AnnualQuarterlyTTM
Revenue
$23.25B
Fiscal year ended 2026-06-30
Operating income
$2.48B
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

BECTON DICKINSON & CO (BDX) reported revenue of $23.25B and net income of $941.00M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from BECTON DICKINSON & CO’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

BECTON DICKINSON & CO income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$23.25B
Cost of revenue$12.34B
Gross profit$10.91B
Operating income$2.48B
Net income$941.00M
Research & development$1.37B
Weighted-average diluted sharesUnavailable
Pretax income$1.96B
Income tax expense$241.00M
Diluted EPSUnavailable
Selling, general & administrative$5.71B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

BECTON DICKINSON & CO balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$708.00M
Total assets$50.73B
Current assets$8.14B
Total liabilitiesUnavailable
Current liabilities$9.40B
Total equity incl. NCI$24.42B
Temporary (mezzanine) equityUnavailable
Inventory$3.32B
Accounts receivable$2.36B
Goodwill$25.94B
Long-term debt$13.51B
Accounts payableUnavailable

Cash flow

BECTON DICKINSON & CO cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flowUnavailable
Capital expenditures$753.00M
Investing cash flowUnavailable
Financing cash flowUnavailable
Net change in cash$146.00M
Stock-based compensation$283.00M
Common dividends paidUnavailable
Common share repurchases$2.50B
Depreciation & amortization$2.50B

Derived

BECTON DICKINSON & CO derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin46.9%
Operating margin10.7%
FCF marginUnavailable
SBC / revenue1.2%
Current ratio0.87x
Revenue YoY growth17.4%
Net margin4.0%
R&D / revenue5.9%
CapEx / revenue3.2%
Long-term debt / equity0.55x
Effective tax rate12.3%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BDX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-Q · Filed 2026-02-09View SEC filing
10-K · Filed 2025-11-25View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-01View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.